Open AccessLow Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients
Author(s) -
Barry D. Kahan,
Yarkın Kamil Yakupoğlu,
L. Schoenberg,
Richard J. Knight,
Stephen M. Katz,
Deijan Lai,
Charles T. Van Buren
Publication year - 2005
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000173770.42403.f7
Subject(s) - medicine , immunosuppression , prednisone , sirolimus , incidence (geometry) , concomitant , malignancy , gastroenterology , population , transplantation , urology , surgery , physics , environmental health , optics
Malignancies, a well-known complication of immunosuppressive therapy in renal transplant recipients, represent an important cause of long-term morbidity and mortality. One approach to addressing this problem is identifying agents that display antineoplastic properties concomitant with their immunosuppressive effects.